Results 81 to 90 of about 5,534,172 (226)
Mycobacterium avium complex (MAC) is a major cause of non-tuberculous pulmonary and disseminated diseases worldwide, inducing bronchiectasis, and affects HIV and immunocompromised patients. In MAC, Mycobacterium avium subsp.
Reaz Uddin +5 more
doaj +1 more source
Nanomaterial Strategies for Pulmonary Delivery of Immunotherapeutics in Lung Cancer Treatment
Inhalable immunotherapeutic nanomedicines enable organ‐selective immune modulation by overcoming pulmonary delivery barriers and concentrating therapy within lung tumors. This Review defines how nanomaterial properties govern airway deposition, retention, cellular partitioning, and immune activation across vaccines, checkpoint blockade, STING agonists,
Han Zhang, Wei Tang
wiley +1 more source
Aminoglycosides are broad‐spectrum antibiotics used in the management of severe infections. Aminoglycosides are associated with nephrotoxicity and ototoxicity. Although dosing strategies such as once‐daily administration and therapeutic drug monitoring have reduced the incidence of nephrotoxicity, ototoxicity remains unpredictable and may occur at ...
John H. McDermott +16 more
wiley +1 more source
Comparación de genes que codifican resistencia antibiótica en Mycobacterium avium Complex y Mycobacterium tuberculosis Complex [PDF]
En la actualidad, los complejos M. avium (MAC) y M. tuberculosis (MTBC) son considerados como agentes etiológicos en enfermedades como la tuberculosis humana, una de las 10 principales causas de mortalidad en el mundo.
Rojas Ospina, Daniel Andrés
core
Acquired immunodeficiency syndrome patients are known to have an increased tendency for developing opportunistic infections. However, there are no reports of simultaneous lymph node involvement of cytomegalovirus and Mycobacterium avium complex in a ...
Arya Hedjazi +2 more
doaj +1 more source
Treatment for Mycobacterium avium complex lung disease
Mycobacterium avium complex (MAC) is the major pathologic nontuberculous mycobacteria causing lung disease (LD) in humans worldwide. Although the burden of MAC-LD has increased over the past two decades, treatment remains difficult because of intolerance
Sheng-Wei Pan +3 more
doaj +1 more source
Lesión cútanea por mycobacterium avium intracelular [PDF]
Mycobacterium avium intracellulare (MAC) is one of the mycobacterias most frequently found in patients with HIV infection, but their frequency is decreasing and has been associated to active antiretroviral therapy (HAART) and prophylactic ...
Gaviria, Mónica Alejandra +2 more
core
Treatment of Mycobacterium avium Complex Pulmonary Disease
The pathogen Mycobacterium avium complex (MAC) is the most common cause of nontuberculous mycobacterial pulmonary disease worldwide. The decision to initiate long-term antibiotic treatment is difficult for the physician due to inconsistent disease ...
Yong-Soo Kwon, M.D. +2 more
doaj
Survey of Mycobacterium spp. in Eurasian Badgers (Meles meles) in Central Italy
A survey to determine the presence of Mycobacterium spp. in the Abruzzo and Molise regions was conducted by testing samples from 124 badgers found dead or road-killed during the 2013–2021 period.
Elga Ersilia Tieri +10 more
doaj +1 more source
Tuberculins purified protein derivatives (PPDs) are obtained by precipitation from heat treated mycobacteria. PPDs are used in diagnosis of mycobacterial infections in humans and animals.
Sara Corneli +8 more
doaj +1 more source

